Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The macrophage phagocytosis pathway encompasses the molecular and cellular processes by which macrophages detect, engulf, and destroy pathogens, apoptotic cells, and cellular debris. This pathway is initiated by the binding of ligands (e.g., antibody-opsonized particles via Fcγ receptors or complement-opsonized particles via complement receptors) to specific receptors on the macrophage surface[1][3]. Receptor engagement triggers a cascade of intracellular signaling events, including the activation of kinases (Syk, PI 3-kinase, PKC, ERK), modulation of phosphoinositide lipids, and dynamic remodeling of the actin and microtubule cytoskeleton to form membrane protrusions that engulf the target[1][3]. The engulfed particle is enclosed within a phagosome, which matures through fusion with endosomes and lysosomes to become a phagolysosome, where the particle is degraded by acidic and enzymatic action[1]. The pathway is critical for innate immunity, inflammation resolution, tissue homeostasis, and wound healing, and its dysregulation is implicated in infections, chronic inflammatory diseases, atherosclerosis, and cancer[1][5]. Macrophage phagocytic capacity and receptor expression can change with differentiation state and environmental cues, highlighting the plasticity and context-dependence of this pathway[1].
Receptor engagement (Fcγ receptor or complement receptor) initiates intracellular signaling cascades. Phosphoinositide metabolism (PI 3-kinase, PLCγ) and lipid remodeling at the phagocytic cup. Cytoskeletal rearrangement (actin polymerization/depolymerization via Arp2/3 complex, Rho, Rac, Cdc42 GTPases). Phagosome formation and maturation via sequential fusion with endosomes and lysosomes. Acidification and enzymatic degradation within the phagolysosome.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Macrophage phagocytosis pathway.